Literature DB >> 32889594

Quantitative Pectoralis Muscle Area is Associated with the Development of Lung Cancer in a Large Lung Cancer Screening Cohort.

Lee Gazourian1, Chantal S Durgana2, Devon Huntley3, Giulia S Rizzo4, William B Thedinger3, Shawn M Regis5, Lori Lyn Price6,7, Elizabeth J Pagura8, Carla Lamb8, Kimberly Rieger-Christ9, Carey C Thomson10,11, Cristina F Stefanescu12, Ava Sanayei3, William P Long3, Andrea B McKee5, George R Washko13,14, Raul San José Estépar14,15, Christoph Wald16, Timothy N Liesching8, Brady J McKee16.   

Abstract

BACKGROUND: Studies have demonstrated an inverse relationship between body mass index (BMI) and the risk of developing lung cancer. We conducted a retrospective cohort study evaluating baseline quantitative computed tomography (CT) measurements of body composition, specifically muscle and fat area in a large CT lung screening cohort (CTLS). We hypothesized that quantitative measurements of baseline body composition may aid in risk stratification for lung cancer.
METHODS: Patients who underwent baseline CTLS between January 1st, 2012 and September 30th, 2014 and who had an in-network primary care physician were included. All patients met NCCN Guidelines eligibility criteria for CTLS. Quantitative measurements of pectoralis muscle area (PMA) and subcutaneous fat area (SFA) were performed on a single axial slice of the CT above the aortic arch with the Chest Imaging Platform Workstation software. Cox multivariable proportional hazards model for cancer was adjusted for variables with a univariate p < 0.2. Data were dichotomized by sex and then combined to account for baseline differences between sexes.
RESULTS: One thousand six hundred and ninety six patients were included in this study. A total of 79 (4.7%) patients developed lung cancer. There was an association between the 25th percentile of PMA and the development of lung cancer [HR 1.71 (1.07, 2.75), p < 0.025] after adjusting for age, BMI, qualitative emphysema, qualitative coronary artery calcification, and baseline Lung-RADS® score.
CONCLUSIONS: Quantitative assessment of PMA on baseline CTLS was associated with the development of lung cancer. Quantitative PMA has the potential to be incorporated as a variable in future lung cancer risk models.

Entities:  

Keywords:  Lung cancer; Lung cancer screening; Quantitive pectoralis muscle area

Mesh:

Year:  2020        PMID: 32889594      PMCID: PMC8710309          DOI: 10.1007/s00408-020-00388-5

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  23 in total

1.  Body mass index and risk of lung cancer among never, former, and current smokers.

Authors:  Llewellyn Smith; Louise A Brinton; Margaret R Spitz; Tram Kim Lam; Yikyung Park; Albert R Hollenbeck; Neal D Freedman; Gretchen L Gierach
Journal:  J Natl Cancer Inst       Date:  2012-03-27       Impact factor: 13.506

2.  Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.

Authors:  Lisa Martin; Laura Birdsell; Neil Macdonald; Tony Reiman; M Thomas Clandinin; Linda J McCargar; Rachel Murphy; Sunita Ghosh; Michael B Sawyer; Vickie E Baracos
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

3.  Body mass index and waist circumference in relation to lung cancer risk in the Women's Health Initiative.

Authors:  Geoffrey C Kabat; Mimi Kim; Julie R Hunt; Rowan T Chlebowski; Thomas E Rohan
Journal:  Am J Epidemiol       Date:  2008-05-15       Impact factor: 4.897

4.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

Review 5.  Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis.

Authors:  Peng Duan; Chunhui Hu; Chao Quan; Xianfu Yi; Wei Zhou; Meng Yuan; Tingting Yu; Ansoumane Kourouma; Kedi Yang
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

6.  Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.

Authors:  Johanna Nattenmüller; Raoul Wochner; Thomas Muley; Martin Steins; Simone Hummler; Birgit Teucher; Joachim Wiskemann; Hans-Ulrich Kauczor; Mark Oliver Wielpütz; Claus Peter Heussel
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

7.  BMI-mortality association: shape independent of smoking status but different for chronic lung disease and lung cancer.

Authors:  David Faeh; Marco Kaufmann; Sarah R Haile; Matthias Bopp
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-06-06

8.  The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey.

Authors:  A A De Graaff; T M D'Hooghe; G A J Dunselman; C D Dirksen; L Hummelshoj; S Simoens
Journal:  Hum Reprod       Date:  2013-07-11       Impact factor: 6.918

9.  Body Mass Index: Obesity, BMI, and Health: A Critical Review.

Authors:  Frank Q Nuttall
Journal:  Nutr Today       Date:  2015-04-07

10.  Body mass index and lung cancer risk: a pooled analysis based on nested case-control studies from four cohort studies.

Authors:  Harinakshi Sanikini; Jian-Min Yuan; Lesley M Butler; Woon-Puay Koh; Yu-Tang Gao; Annika Steffen; Mattias Johansson; Paolo Vineis; Gary E Goodman; Matt J Barnett; Rayjean J Hung; Chu Chen; Isabelle Stücker
Journal:  BMC Cancer       Date:  2018-02-23       Impact factor: 4.430

View more
  4 in total

1.  Preoperative Pectoralis Muscle Index Predicts Distant Metastasis-Free Survival in Breast Cancer Patients.

Authors:  Wen-Juan Huang; Meng-Lin Zhang; Wen Wang; Qing-Chun Jia; Jia-Rui Yuan; Xin Zhang; Shuang Fu; Yu-Xi Liu; Shi-di Miao; Rui-Tao Wang
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

2.  LUNG Year in Review: 2020.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2021-01-26       Impact factor: 2.584

3.  Analysis of Hazard Factors Affecting the Quality of Life for Lung Cancer Patients after Chemotherapy.

Authors:  Lianying Wen; Xiaohong Liao; Yanjin Cao; Yanxiu Liu; Wei Wu; Yan Chen; Huiyu Liu
Journal:  J Healthc Eng       Date:  2022-04-20       Impact factor: 3.822

4.  Qualitative coronary artery calcification scores and risk of all cause, COPD and pneumonia hospital admission in a large CT lung cancer screening cohort.

Authors:  Lee Gazourian; Shawn M Regis; Elizabeth J Pagura; Lori Lyn Price; Melissa Gawlik; Carla Lamb; Kimberly M Rieger-Christ; William B Thedinger; Ava M Sanayei; William P Long; Cristina F Stefanescu; Giulia S Rizzo; Avignat S Patel; Carolyn E Come; Carey C Thomson; Victor Pinto-Plata; Katrina Steiling; Andrea B McKee; Christoph Wald; Brady J McKee; Timothy N Liesching
Journal:  Respir Med       Date:  2021-07-12       Impact factor: 4.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.